Pharmacological approaches to defining the role of chaperones in aging and prostate cancer progression.
Harvey
Sarah A
SA
Department of Pharmacology and Toxicology, Medical College of Virginia at Virginia Commonwealth University, Richmond 23298-0662, USA.
Jensen
Keith O
KO
Elmore
Lynne W
LW
Holt
Shawn E
SE
D000375:Aging / Q000235:genetics / Q000502:physiology*; D000818:Animals; D016227:Benzoquinones; D016922:Cellular Senescence / Q000235:genetics / Q000502:physiology*; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D047029:Lactams, Macrocyclic; D007783:Lactones / Q000494:pharmacology; D018942:Macrolides; D008297:Male; D051379:Mice; D018832:Molecular Chaperones / Q000187:drug effects / Q000502:physiology*; D011471:Prostatic Neoplasms / Q000503:physiopathology*; D011809:Quinones / Q000494:pharmacology; D019098:Telomerase / Q000096:biosynthesis; D016615:Telomere / Q000235:genetics / Q000502:physiology
D016227:Benzoquinones; D018841:HSP90 Heat-Shock Proteins; D047029:Lactams, Macrocyclic; D007783:Lactones; D018942:Macrolides; D018832:Molecular Chaperones; D011809:Quinones; D019098:Telomerase; C035359:monorden; C001277:geldanamycin